This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Keynote Panel— Former Secretaries on What’s Next for the VA Moderator: Thomas Bowman , Former Deputy Secretary of Veterans Affairs (2017-2018), CEO, TGB Strategies (confirmed) Anthony Principi , Former Secretary of Veterans Affairs (2001- 2005), Principal, The Principi Group (confirmed) Dr. James Peake , M.D., NW, Washington, D.C.
Keynote Panel— Former Secretaries on What’s Next for the VA Moderator: Thomas Bowman , Former Deputy Secretary of Veterans Affairs (2017-2018), CEO, TGB Strategies (confirmed) Anthony Principi , Former Secretary of Veterans Affairs (2001- 2005), Principal, The Principi Group (confirmed) Dr. James Peake , M.D., NW, Washington, D.C.
Don’t miss your chance to participate in the Joseph P. 2001), which concluded that the COFC has bid protest jurisdiction over United States Postal Service procurements despite that the Postal Service being exempt from the FAR). According to CMS, 15 more Part D drugs will be selected for negotiation for 2027 by February 1, 2025.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2001 
52 
Let's personalize your content